| Combined Intravitreal Triamcinolone-Bevacizumab Treatment in Refractory Diabetic Macular Edema | Handan BARDAK,Yavuz BARDAK,Mustafa Muhterem EKİM | 189–194 |
| Effect of Preoperative Macular Structure on Postoperative Visual Acuity in Retinal Detachment with Macular Involvment | Handan BARDAK,Yavuz BARDAK | 195–200 |
| Intravitreal Bevacizumab Treatment in Type 1 Idipathic Macular Telangiectasia | Tuğba AYDOĞAN,MUSTAFA GÜRKAN ERDOĞAN,Cihan ÜNLÜ,Esra KARDEŞ,Ahmet ERGİN | 201–204 |
| Relationship Between Serous Retinal Detachment and Serum Glycosylated Hemoglobin Levels in Diabetic Macular Edema | Erkan ÇELİK,Emine DOĞAN,Burçin KÖKLÜ,Şule COŞKUN,Sibel ALİŞAN,Gürsoy ALAGÖZ | 205–208 |
| Evaluation of the Long Term Foveal Changes in Spontaneously Healed Central Serous Retinopathy Patients with Optical Cohorens Tomography | Fahrettin AKAY,Sami TOYRAN,Ümit YOLCU,Fatih Çakır GÜNDOĞAN | 209–213 |
| Changes in Subfoveal Choroidal Thickness and Macular Thickness After Panretinal Photocoagulation | Tamer ERYİĞİT,Üzeyir Tolga ŞAHANDAR | 214–217 |
| The Results of a 12 Month Follow-up of an Intravitreal Dexamethasone Implantation in Persistent Diabetic Macular Edema | Eren CERMAN,Alev KÖSE ÖZÇELİK,Özlem ŞAHİN | 218–222 |
| Clinical-Anatomic Correlation in Central Serous Chorioretinopathy | Nimet YEŞİM ERÇALIK,Serhat İMAMOĞLU,Nursal Melda YENEREL,Esra KUMRAL TÜRKSEVEN,Gökhan ARSLAN,Handan BARDAK,Yavuz BARDAK | 223–226 |
| Short Term Clinical Outcomes For Intravitreal Dexamethasone Implant in Retinal Vein Occlusion Patients | Samet GÜLKAŞ,ÖZLEM NACİYE ATAN ŞAHİN | 227–231 |
| Combined Phacoemulsification and Silicone Oil Removal Through Posterior Capsulorhexis | Faruk KAYA,İbrahim KOÇAK,Ali AYDIN,Hakan BAYBORA,Salih BOZKURT | 232–235 |
| Yırtıklı Retina Dekolmanı ve Koroid Dekolmanı Beraberliğinde Tedavi Yaklaşımımız* | Eren CERMAN,OSMAN ÇEKİÇ,Volkan DERİCİOĞLU | 236–238 |
| A Case of Sjogren's Reticular Distrophy Using Multimodal Imaging |